← FDA DRUG APPROVALS

FDA ANDA · ANDA064022

NYSTATIN

Sponsor: SUN PHARMA CANADA

APPLICATION
ANDA064022
TYPE
ANDA
ORIGINAL APPROVAL
1993-01-29
LATEST ACTION
1996-09-17
ROUTE
TOPICAL
DOSAGE FORM
CREAM
MARKETING STATUS
Prescription

Products

NYSTATINPrescription
NYSTATIN 100,000 UNITS/GM · CREAM · TOPICAL

Approval history

1996-09-17Manufacturing (CMC) · Supplement 2AP
1996-04-30Manufacturing (CMC) · Supplement 1AP
1993-01-29OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →